Pharvinex Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.47 Cr
- Revenue Growth 42.67%
- Profit Growth 44.56%
- Ebitda 34.89%
- Net Worth 73.75%
- Total Assets 1.22%
About Pharvinex Healthcare
Pharvinex Healthcare Private Limited (PHPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2016 (Eight years and eight months 13 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.47 Cr.
Ananta Kanungo and Ranjan Behera serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24200TG2016PTC110103
-
Company No.
110103
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jun 2016
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharvinex Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ananta Kanungo
|
Director | 10-Sep-2016 | Current |
|
Ranjan Behera
|
Director | 24-May-2017 | Current |
Financial Performance of Pharvinex Healthcare.
Pharvinex Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.67% increase. The company also saw a substantial improvement in profitability, with a 44.56% increase in profit. The company's net worth Soared by an impressive increase of 73.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharvinex Healthcare?
In 2022, Pharvinex Healthcare had a promoter holding of 45.50% and a public holding of 54.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹24.71 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2024 | Others | ₹1.72 Cr | Open |
| 30 Dec 2022 | Others | ₹7.50 M | Open |
How Many Employees Work at Pharvinex Healthcare?
Unlock and access historical data on people associated with Pharvinex Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharvinex Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharvinex Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
